Study comparing human papillomavirus (HPV) real-time multiplex PCR and hybrid capture II INNO-LiPA v2 HPV genotyping PCR assays

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2106-2113

  Iftner, Thomas ^a   Germ, Liesje ^b,f   Swoyer, Ryan ^b   Kjaer, Susanne Kruger ^c   Breugelmans, J Gabrielle ^d,e   Munk, Christian ^c   Stubenrauch, Frank ^a   Antonello, Joseph ^b   Bryan, Janine T ^b   Taddeo, Frank J ^b,f  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MERCK RESEARCH LABORATORIES   (United States)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d SANOFI PASTEUR   (France)

^e INSTITUT PASTEUR   (France)

^f Pharmaceutical Product Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 68; HYBRIDIZATION; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 67650072497     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01907-08     Document Type: Article

References (15)

1. Brennan, M. M., H. A. Lambkin, C. D. Sheehan, D. D. Ryan, T. C. O'Connor, and W. F. Kealy. 2001. Detection of high-risk subtypes of human papillomavirus in cervical swabs: routine use of the Digene Hybrid Capture assay and polymerase chain reaction analysis. Br. J. Biomed. Sci. 58:24-29.
2. FUTURE II Study Group. 2007. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356:1915-1927.
3. Garland, S. M., M. Hernandez-Avila, C. M. Wheeler, G. Perez, D. M. Harper, S. Leodolter, G. W. K. Tang, D. G. Ferris, M. Steben, J. T. Bryan, F. J. Taddeo, R. Railkar, M. T. Esser, H. L. Sings, M. Nelson, J. Boslego, C. Sattler, E. Barr, and L. A. Koutsky. 2007. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356:1928-1943.
4. Gheit, T., S. Landi, F. Gemignani, P. J. Snijders, S. Vaccarella, S. Franceschi, F. Canzian, and M. Tommasino. 2006. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J. Clin. Microbiol. 44:2025-2031.
5. Jansen, K., F. J. Taddeo, L. Weili, and A. C. DiCello. March 2003. Fluorescent multiplex HPV PCR assays using multiple fluorophores. WO patent 2003/019143 A2.
6. Kjaer, S. K., G. Breugelmans, and C. Munk. 2008. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of HPV-vaccination program in Denmark. Int. J. Cancer 123:1864-1870.
7. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
8. Safaeian, M., R. Herrero, A. Hildesheim, W. Quint, E. Freer, L. J. van Doorn, C. Porras, S. Silva, P. Gonzalez, M. C. Bratti, A. C. Rodriguez, and P. Castle. 2007. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45:1447-1454.
9. Sotlar, K., A. Stubner, D. Diemer, S. Menton, M. Menton, K. Dietz, D. Wallwiener, R. Kandolf, and B. Bultmann. 2004. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J. Med. Virol. 74:107-116.
10. Taddeo, F. J., D. M. Skulsky, X. M. Wang, and K. U. Jansen. November 2006. Real-time HPV PCR assays. WO patent 2006/116276 A2.
11. Taddeo, F. J., D. M. Skulsky, X. M. Wang, and K. U. Jansen. November 2006. Fluorescent multiplex HPV PCR assay. WO patent 2006/116303 A2.
12. van Doorn, L. J., A. Molijn, B. Kleter, W. Quint, and B. Colau. 2006. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol. 44:3292-3298.
13. van Hamont, D., M. A. van Ham, J. M. Bakkers, L. F. Massuger, and W. J. Melchers. 2006. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J. Clin. Microbiol. 44:3122-3129.
14. Walboomers, J. M. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, A. Kummer, K. V. Shah, and P. J. F. Snijders. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
15. World Health Organization. 2004. Human papillomavirus infection and cervical cancer. World Health Organization, Geneva, Switzerland. http://www.who.int/vaccine-research/diseases/hpv/en/.